Editorial Policies

Focus and Scope

The journal includes various fields of pharmaceutical sciences, such as:

  1. Pharmaceutical Technology
  2. Pharmacology and Toxicology
  3. Pharmaceutical Chemistry
  4. Pharmaceutical Biology
  5. Clinical and Community of Pharmacy
  6. Management of Pharmacy
  7. Biopharmaceutics
  8. Pharmaceutical Microbiology and Biotechnology
  9. Pharmacocinetics
  10. Alternative Medicines

 

Section Policies

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

All manuscripts will be subject to editorial review and double blind peer reviews. The Journal editor does not reveal the reviewers credentials to the authors and vice-versa. So both parties are not aware of each other's identity. All indicators of identity such as names, affiliations, etc are removed. Submitted manuscripts will generally be reviewed by two to three experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. Reviewers will also be asked to indicate how interesting and significant the research is.

The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board. Based on the reviewers comments, the editors will then accept or reject the papers with the following conditions:

  1. Accept and publish, with or without editorial revisions
  2. Invite the authors to revise their manuscript and address specific concerns
  3. Reject the article outright, typically on grounds of lack of originality, insufficient conceptual advancements or major technical and/or interpretational problems

Any changes made to the original manuscript will be clearly stated for the authors to review. The authors should carefully examine sentence structure, the completeness and accuracy of the text, references, tables, and graphic contents of the revised manuscript. The Editor-in-Chief will have the final decision regarding acceptance or rejection of manuscripts. The Editorial Board reserves the right to edit articles on all aspects of style, format, and clarity. Manuscripts with excessive errors in any aspect, i.e. spelling or punctuation, will be returned to authors for revision before resubmission or may be rejected entirely. The time to reach a final decision depends on the number of reviews rotation, perceptive writer etc. Typically, the time frame of delivery by an average of 2-3 months a final decision.

 

Publication Frequency

PHRASE Journal is published twice a year in April and October

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

 

Publication Ethics

PHRASE (Pharmaceutical Science) Journal is a peer-reviewed journal that aspires to be a leading peer-reviewed platform and authoritative source of information. Original research papers in pharmaceutical science, such as Pharmaceutical Technology, Pharmacology, Pharmaceutical Chemistry, Biopharmaceutics, Pharmacocinetics, Clinical and Community of Pharmacy, and Alternative Medicines, are published by STIKes Widya Dharma Husada. This statement clarifies the ethical behavior of all parties involved in the act of publishing an article in this journal, including the author, editor, reviewer, and publisher (STIKes Widya Dharma Husada). This statement is based on the COPE'S Best Practice Guidelines for Journal Editors.


Ethical Guideline for Journal Publication

The publication of an article in a peer-reviewed Phrase is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore essential to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer-reviewer, the publisher and the society.

The STIKes Widya Dharma Husada Tangerang as publisher of Phrase takes its duties of guardianship over all stages of publishing seriously, and we recognize our ethical and other responsibilities. We are committed to ensuring that advertising, reprint or additional commercial revenue has no impact or influence on editorial decisions. Besides, the STIKes Widya Dharma Husada Tangerang, and the Editorial Board will assist in communications with other journals and publishers where this is useful and necessary.


Publication decisions

The editor of the Phrase is responsible for deciding which of the articles submitted to the journal should be published. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editors may confer with other editors or reviewers in making this decision.


Fair play

An editor at any time evaluates manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.


Confidentiality

The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.


Disclosure and conflicts of interest

Unpublished materials disclosed in a submitted manuscript must not use in an editor's research without the express written consent of the author.


Duties of Peer-Reviewers

  1. Contribution to Editorial Decisions

    Peer-reviewers assist the editor in making editorial decisions and through the editorial communications with the author may also help the author in improving the paper.

  2. Promptness

    Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

  3. Confidentiality

    Any manuscripts received for review must be considered as confidential documents. They must not be shown to or discussed with others except as authorised by the editor.

  4. Standards of Objectivity

    Peer-review process should conduct objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

  5. Acknowledgement of Sources

    Peer-reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument reported should accompany by the appropriate citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

  6. Disclosure and Conflict of Interest

    Privileged information or ideas obtained through peer-review must be kept confidential and not used for personal advantage. Peer-reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.


Duties of Authors

  1. Reporting standards

    Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.

  2. Data Access and Retention

    Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

  3. Originality and Plagiarism

    The authors should ensure that they have written entirely original actions and if the authors have used the works, or words of others that this has appropriately cited or quoted.

  4. Multiple, Redundant or Concurrent Publication

    An author should not, in general, publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same paper concurrently to more than one journal constitutes unethical publishing behavior and is unacceptable.

  5. Acknowledgement of Sources

    Proper acknowledgment of the work of others must always be provided. Authors should cite publications that have been influential in determining the nature of the reported work.

  6. Authorship of the Paper

    Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper and that all co-authors have seen and approved the final version of the article and have agreed to its submission for publication.

  7. Fundamental errors in published works

    When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

 

Screening For Plagiarism

Plagiarism is a major concern for PHRASE (Pharmaceutical Sciences) Journal. The authors should ensure that their works are entirely original, and if they have used the work and/or words of others, this has been properly cited or quoted. When an author attempts to pass off someone else's work as his or her own, this is referred to as plagiarism. Duplicate publication, also known as self-plagiarism, occurs when an author reuses substantial parts of his or her own published work without properly referencing it. This can range from having the same paper published in multiple journals to'salami-slicing,' which is when authors add small amounts of new data to a previous paper.

Plagiarism is clearly demonstrated when large chunks of text are cut and pasted. Such manuscripts will not be accepted for publication in PHRASE. Minor plagiarism with no malicious intent, on the other hand, is fairly common, such as when an author reuses parts of an introduction from an earlier paper. The PHRASE editors evaluate each case on its own merits (either through their own knowledge of and reading about the literature or when alerted by referees). Papers submitted to PHRASE will be screened and checked for plagiarism using Turnitin, but an author should be checked it to before submitted.

 

Publication Fees

No fees incurred for article processing, submission, neither reviewing the articles.

Under the aforementioned condition, we are waiving in full for authors from developing countries should they need to submit papers to Phrase

Please send us an email if you interest in printed copies and receive further details.